The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
Department of Surgical Oncology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Front Endocrinol (Lausanne). 2022 Aug 8;13:974755. doi: 10.3389/fendo.2022.974755. eCollection 2022.
Accurate evaluation of the risk of papillary thyroid microcarcinoma (PTMC) is the key to treatment. However, the maximum diameter (MD), which is currently used in various staging systems, may not truly reflect the aggressiveness of multifocal tumors.
Clinical and pathological data for 1001 patients with papillary thyroid carcinoma who underwent surgery at the Hangzhou First People's Hospital were retrospectively analyzed. First, the relationship between total tumor diameter (TTD) and clinicopathological features in multifocal PTMC was explored. Then, patients were divided into subgroups according to the TTD. The baseline was consistent after using the propensity score matching method, and the differences between groups were compared. In addition, the effectiveness of TTD and MD in evaluating central lymph node metastasis (CLNM) was analyzed and compared.
TTD is associated with a range of clinicopathological features, including lymph node metastasis, extrathyroidal extension, and risk stratification. Assuming the same MD and number of foci, the invasiveness of multifocal PTMC with TTD >1 cm was significantly higher than that with TTD <1 cm, and even higher than unifocal non-PTMC. Moreover, the efficiency of TTD in predicting CLNM was also significantly higher than that of MD.
For multifocal PTMC, TTD is a more realistic indicator of tumor biological characteristics than MD. The aggressiveness of PTMC with TTD >1 cm was significantly enhanced, and surgical treatment should be actively sought in such cases.
准确评估甲状腺微小乳头状癌(PTMC)的风险是治疗的关键。然而,目前在各种分期系统中使用的最大直径(MD)可能并不能真实反映多灶性肿瘤的侵袭性。
回顾性分析了杭州市第一人民医院 1001 例接受手术治疗的甲状腺乳头状癌患者的临床和病理资料。首先,探讨了总肿瘤直径(TTD)与多灶性 PTMC 患者临床病理特征之间的关系。然后,根据 TTD 将患者分为亚组。采用倾向评分匹配法使基线一致后,比较组间差异。此外,还分析并比较了 TTD 和 MD 在评估中央淋巴结转移(CLNM)中的有效性。
TTD 与多种临床病理特征相关,包括淋巴结转移、甲状腺外侵犯和危险分层。假设 MD 和病灶数量相同,TTD >1cm 的多灶性 PTMC 的侵袭性明显高于 TTD <1cm 的多灶性 PTMC,甚至高于单发非 PTMC。此外,TTD 预测 CLNM 的效率也明显高于 MD。
对于多灶性 PTMC,TTD 是比 MD 更能反映肿瘤生物学特征的指标。TTD >1cm 的 PTMC 的侵袭性明显增强,此类患者应积极寻求手术治疗。